Cite
Glucose-6-phosphate dehydrogenase: a possible clinical indicator for prostatic carcinoma.
MLA
Zampella, Edward J., et al. “Glucose-6-Phosphate Dehydrogenase: A Possible Clinical Indicator for Prostatic Carcinoma.” Cancer (0008543X), vol. 49, no. 2, Jan. 1982, pp. 384–87. EBSCOhost, https://doi.org/10.1002/1097-0142(19820115)49:2<384::AID-CNCR2820490229>3.0.CO;2-1.
APA
Zampella, E. J., Bradley, E. L., Pretlow, T. G., Zampella, E. J., Bradley, E. L., Jr, & Pretlow, T. G., 2nd. (1982). Glucose-6-phosphate dehydrogenase: a possible clinical indicator for prostatic carcinoma. Cancer (0008543X), 49(2), 384–387. https://doi.org/10.1002/1097-0142(19820115)49:2<384::AID-CNCR2820490229>3.0.CO;2-1
Chicago
Zampella, Edward J., Edwin L. Bradley, Thomas G. Pretlow, E J Zampella, E L Bradley Jr, and T G Pretlow 2nd. 1982. “Glucose-6-Phosphate Dehydrogenase: A Possible Clinical Indicator for Prostatic Carcinoma.” Cancer (0008543X) 49 (2): 384–87. doi:10.1002/1097-0142(19820115)49:2<384::AID-CNCR2820490229>3.0.CO;2-1.